Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "BioE3-policy"

12 News Found

BioE3 policy accelerates India’s biomanufacturing ambitions with biofoundries, AI hubs & space biotech
Policy | April 03, 2026

BioE3 policy accelerates India’s biomanufacturing ambitions with biofoundries, AI hubs & space biotech

Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors


DBT highlights role of biomanufacturing in climate action
Policy | June 06, 2026

DBT highlights role of biomanufacturing in climate action

The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development


From lab bench to market: Strengthening translational research in India’s biotech ecosystem
Opinion | May 11, 2026

From lab bench to market: Strengthening translational research in India’s biotech ecosystem

India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells


India’s bio-economy to hit $1 trillion by 2047: Dr Jitendra Singh
Policy | April 25, 2026

India’s bio-economy to hit $1 trillion by 2047: Dr Jitendra Singh

At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones


India’s bioeconomy hits $165.7 billion as govt unveils fresh biopharma push
Biotech | April 03, 2026

India’s bioeconomy hits $165.7 billion as govt unveils fresh biopharma push

DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports


Natural Biogenex joins forces with Fermbox Bio to boost fermentation-based biomanufacturing
Biotech | March 14, 2026

Natural Biogenex joins forces with Fermbox Bio to boost fermentation-based biomanufacturing

The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand


Dr. Jitendra Singh inaugurates 10th Annual
Biotech | October 11, 2025

Dr. Jitendra Singh inaugurates 10th Annual "Cell and Gene Therapy" symposium

Several technologies for hemoglobinopathies are being transferred to commercial partners


Rise of Bio-based Chemicals: Hype or Game-Changer?: Dr. Sangeeta Srivastava, Executive Director, Godavari Biorefineries
Opinion | July 28, 2025

Rise of Bio-based Chemicals: Hype or Game-Changer?: Dr. Sangeeta Srivastava, Executive Director, Godavari Biorefineries

The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production


India’s biotech economy set to reach a massive $300 bn by 2030: Dr. Jitendra Singh
Policy | March 07, 2025

India’s biotech economy set to reach a massive $300 bn by 2030: Dr. Jitendra Singh

Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored